← Back to Search

Herbal Supplement

Lagenbone for Osteoporosis

N/A
Waitlist Available
Led By Prasad S Vinjamury, DACM, MPH
Research Sponsored by Southern California University of Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to receive routine DEXA scans and comply with supplement schedule
Confirmed diagnosis of osteoporosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 months
Awards & highlights

Study Summary

Effects of Lagenbone on Bone Mineral Density

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dual-energy x-ray absorptiometry (DXA)DEXA Scan
Secondary outcome measures
36-item Short form survey (SF36)
Osteoporotic Quality of Life Questionnaire (OQLQ10)
Short Osteoporosis Quality of Life Questionnaire (ECOS16)

Trial Design

1Treatment groups
Experimental Treatment
Group I: LagenboneExperimental Treatment1 Intervention
Lagenbone 500mg capsules, 8 capsules by mouth every day for 12 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lagenbone
2019
N/A
~10

Find a Location

Who is running the clinical trial?

Southern California University of Health SciencesLead Sponsor
9 Previous Clinical Trials
411 Total Patients Enrolled
Sun Ten Pharmaceutical Co., Ltd.Industry Sponsor
1 Previous Clinical Trials
260 Total Patients Enrolled
Sun Ten Pharmaceutical Co Ltd.UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for participants in this research experiment?

"The study, which was first uploaded on July 15th 2019, is not currently accepting any more enrollees. This information can be found on clinicaltrials.gov and the last update to this trial occurred September 30th 2022. Meanwhile, 138 other trials are actively recruiting patients for participation at present."

Answered by AI

Is it possible to join the clinical experiment presently?

"This research endeavour requires participants to have osteoporosis, and be between 40-80 years of age. Currently, the team is trying to source 10 individuals for this trial."

Answered by AI

Does the eligibility criterion for this clinical trial include individuals above thirty years of age?

"In accordance with the study's entry conditions, participants must be of at least 40 years old and no older than 80."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
65+
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Effects of Lagenbone on Bone Mineral Density
Sivarama Vinjamury 2019. "Effects of Lagenbone on Bone Mineral Density". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04557553.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top